Glucose Intravenous Bp B. Braun Medical (Glucose Monohydrate)

Glucose Intravenous Bp B. Braun Medical is indicated for several clinical situations where rapid glucose delivery is required. It supports patients who cannot receive nutrition orally or enterally and helps maintain blood sugar levels.

• Treatment of acute hypoglycemia in emergency or perioperative settings.
• Component of parenteral nutrition regimens for patients with limited oral intake.
• Fluid and electrolyte replacement during surgery or critical illness.
• Support for patients with metabolic disorders requiring controlled glucose infusion.
• Adjunct therapy during dialysis to prevent hypoglycemia.

Glucose Intravenous Bp B. Braun Medical may cause a range of reactions, most of which are mild and transient. Serious adverse events are uncommon but require prompt medical attention.

Common

• Local irritation or pain at the infusion site.
• Mild hyperglycemia (elevated blood glucose levels).
• Nausea or vomiting.
• Headache.
• Transient electrolyte imbalance (e.g., low potassium).

Serious

• Severe hyperglycemia leading to diabetic ketoacidosis.
• Allergic reaction or anaphylaxis.
• Fluid overload causing pulmonary edema.
• Severe electrolyte disturbances (e.g., hypernatremia).

When using Glucose Intravenous Bp B. Braun Medical, clinicians should assess patient-specific factors and monitor relevant parameters. Proper precautions help minimize risks.

• Verify blood glucose levels before and during infusion to avoid hyperglycemia.
• Assess fluid status to prevent overload, especially in patients with cardiac or renal impairment.
• Monitor electrolytes, particularly potassium and sodium, during prolonged therapy.
• Use aseptic technique to reduce infection risk.
• Adjust infusion rate in patients with diabetes mellitus or insulin therapy.
• Consider compatibility with other intravenous solutions before co‑administration.

Glucose Intravenous Bp B. Braun Medical can interact with other medications, influencing glucose metabolism or fluid balance. Awareness of these interactions supports safe use.

Avoid

• Concurrent administration of high‑dose insulin without appropriate glucose monitoring.
• Co‑infusion with potassium chloride solutions that may precipitate.
• Use with hypertonic saline solutions that could exacerbate fluid overload.

Use with caution

• Diabetic medications (e.g., sulfonylureas, meglitinides) that may increase risk of hypoglycemia.
• Corticosteroids, which can raise blood glucose levels.
• Loop diuretics, which may affect electrolyte balance.
• Beta‑adrenergic agonists that can alter glucose metabolism.